Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.5
-160.34%
40%
—
36x
33%
—
5 Years
Score3.5
Net Growth-160.34%
Net Trend40%
Net Income Consistency—
Rev Growth36x
Rev Trend33%
Revenue Consistency—
Crescent Biopharma, Inc. fundamental performance
Between 2020 and 2025, revenue grew from $ 10M to $ 10M and net income went from -$ 51M to -$ 153M. Revenue increased in 2 of those 5 years; net income in 2.
Between 2015 and 2025, revenue declined from $ 20M to $ 10M and net income went from -$ 12M to -$ 153M. Revenue increased in 3 of those 10 years; net income in 3.
Crescent Biopharma, Inc. currently holds a 5-year HDB Score of 3.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 16.43 | — |
1 Year2025-08-12 | $ 12.98 | 26.58% |
5 Years2021-08-12 | $ 186.08 | -91.17% |
10 Years2016-08-12 | $ 735.17 | -97.77% |
All Time2014-01-10 | $ 825.92 | -98.01% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2014-01-10 |
|---|---|---|---|---|---|
| Price | $ 16.43 | $ 12.98 | $ 186.08 | $ 735.17 | $ 825.92 |
| Return | — | 26.58% | -91.17% | -97.77% | -98.01% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 42M | -$ 165M | $ 171M |
| 2025 | $ 10M | -$ 153M | $ 213M |
| 2024 | -$ 48M | $ 34M | |
| 2023 | $ 10K | -$ 36M | $ 41M |
| 2022 | $ 75K | -$ 46M | $ 47M |
| 2021 | $ 1M | -$ 63M | $ 90M |
| 2020 | $ 10M | -$ 51M | $ 137M |
| 2019 | -$ 54M | $ 158M | |
| 2018 | -$ 48M | $ 209M | |
| 2017 | -$ 33M | $ 123M | |
| 2016 | $ 18.5K | -$ 31M | $ 40M |
| 2015 | $ 20M | -$ 12M | $ 46M |
| IPO2014 | $ 15M | -$ 11M | $ 55M |
Explore beyond CBIO
You're looking at Crescent Biopharma, Inc.. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
